H Ohno

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. ncbi The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma
    H Ohno
    Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan
    Leuk Lymphoma 36:435-45. 2000
  2. ncbi Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors
    N Yonetani
    First Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
    Jpn J Cancer Res 92:933-40. 2001
  3. ncbi Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms
    H Ohno
    Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan
    Leuk Lymphoma 27:53-63. 1997
  4. ncbi Establishment and characterization of a new human myeloma cell line, KYdelta-1, producing the delta/kappa type immunoglobulin
    C Ueda
    First Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, 54-Shogoin-Kawaramachi, 606-8507, Sakyo-ku, Kyoto, Japan
    Cancer Genet Cytogenet 130:42-50. 2001
  5. ncbi Pathogenetic role of BCL6 translocation in B-cell non-Hodgkin's lymphoma
    H Ohno
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Histol Histopathol 19:637-50. 2004
  6. ncbi A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma results in replacement of the 5' regulatory region of BCL6 with a novel H4 histone gene
    T Akasaka
    Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan
    Cancer Res 57:7-12. 1997
  7. ncbi Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease
    N Yonetani
    Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan
    Int J Hematol 74:178-85. 2001

Collaborators

Detail Information

Publications7

  1. ncbi The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma
    H Ohno
    Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan
    Leuk Lymphoma 36:435-45. 2000
    ....
  2. ncbi Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors
    N Yonetani
    First Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
    Jpn J Cancer Res 92:933-40. 2001
    ....
  3. ncbi Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms
    H Ohno
    Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan
    Leuk Lymphoma 27:53-63. 1997
    ..At present, limited information is available about the functional consequences of the rearrangements and, in particular, about their ultimate implications for lymphomagenesis...
  4. ncbi Establishment and characterization of a new human myeloma cell line, KYdelta-1, producing the delta/kappa type immunoglobulin
    C Ueda
    First Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, 54-Shogoin-Kawaramachi, 606-8507, Sakyo-ku, Kyoto, Japan
    Cancer Genet Cytogenet 130:42-50. 2001
    ..Point mutations within the P53 and N-RAS genes were presumably related to the rapidly progressive disease in this particular MM patient...
  5. ncbi Pathogenetic role of BCL6 translocation in B-cell non-Hodgkin's lymphoma
    H Ohno
    Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Histol Histopathol 19:637-50. 2004
    ....
  6. ncbi A recurring translocation, t(3;6)(q27;p21), in non-Hodgkin's lymphoma results in replacement of the 5' regulatory region of BCL6 with a novel H4 histone gene
    T Akasaka
    Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan
    Cancer Res 57:7-12. 1997
    ..Because H4 gene expression is tightly coupled to DNA replication, this study suggested an immediate mechanism for deregulated expression of BCL6, leading to the development of non-Hodgkin's lymphoma...
  7. ncbi Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease
    N Yonetani
    Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan
    Int J Hematol 74:178-85. 2001
    ..With the exception of 1 patient who was primarily refractory to therapy, 9 patients (90%) achieved complete response and 7 (70%) remain in continuous remission with a mean follow-up of 24 months...